| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Daniel Porte Jr, 13 August 1931–13 May 2023
|
Kahn, Steven E.
|
|
|
66 |
10 |
p. 1759-1761
|
article
|
| 2 |
Genetic associations vary across the spectrum of fasting serum insulin: results from the European IDEFICS/I.Family children’s cohort
|
Mehlig, Kirsten
|
|
|
66 |
10 |
p. 1914-1924
|
article
|
| 3 |
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study
|
Kosjerina, Vanja
|
|
|
66 |
10 |
p. 1908-1913
|
article
|
| 4 |
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
|
Tschöp, Matthias
|
|
|
66 |
10 |
p. 1796-1808
|
article
|
| 5 |
Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production
|
Riahi, Yael
|
|
|
66 |
10 |
p. 1925-1942
|
article
|
| 6 |
Incretin hormones and type 2 diabetes
|
Nauck, Michael A.
|
|
|
66 |
10 |
p. 1780-1795
|
article
|
| 7 |
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
|
Solini, Anna
|
|
|
66 |
10 |
p. 1820-1831
|
article
|
| 8 |
Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
|
Goldney, Jonathan
|
|
|
66 |
10 |
p. 1832-1845
|
article
|
| 9 |
Incretins beyond type 2 diabetes
|
Mathieu, Chantal
|
|
|
66 |
10 |
p. 1809-1819
|
article
|
| 10 |
Incretins: turning the venom into the antidote
|
Krook, Anna
|
|
|
66 |
10 |
p. 1762-1764
|
article
|
| 11 |
Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial
|
Garrib, Anupam
|
|
|
66 |
10 |
p. 1882-1896
|
article
|
| 12 |
Reversal of dual epigenetic repression of non-canonical Wnt-5a normalises diabetic corneal epithelial wound healing and stem cells
|
Shah, Ruchi
|
|
|
66 |
10 |
p. 1943-1958
|
article
|
| 13 |
SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
|
Anson, Matthew
|
|
|
66 |
10 |
p. 1869-1881
|
article
|
| 14 |
Socioeconomic aspects of incretin-based therapy
|
Karagiannis, Thomas
|
|
|
66 |
10 |
p. 1859-1868
|
article
|
| 15 |
Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial
|
Kobayashi, Yukari
|
|
|
66 |
10 |
p. 1897-1907
|
article
|
| 16 |
The expanding incretin universe: from basic biology to clinical translation
|
Drucker, Daniel J.
|
|
|
66 |
10 |
p. 1765-1779
|
article
|
| 17 |
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
|
Andreasen, Christine R.
|
|
|
66 |
10 |
p. 1846-1858
|
article
|
| 18 |
Up Front
|
|
|
|
66 |
10 |
p. 1757-1758
|
article
|
Journal description